Post by Genmab

Every scientific breakthrough at Genmab starts with a shared purpose: bringing innovative and meaningful solutions to patients.      During this edition of #AntibodyHour 🕙, our colleague Farshid Alemdehy, Senior Scientist, Translational Medicine and Research, shares how his team works to bridge preclinical and early clinical development with the ambition to transform science into meaningful benefits for patients.      He shares his perspective on how cancer therapies require a multidimensional approach—combining different strategies to attack the disease from multiple angles, and how this mindset is reflected in Genmab's collaborative culture, where deep science and collaboration help drive innovation forward.      Watch to learn more.

Video Content